OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury
Vishwadeep Shelke, Ajinath Kale, Neha Dagar, et al.
Food & Function (2023) Vol. 14, Iss. 11, pp. 5391-5403
Closed Access | Times Cited: 12
Vishwadeep Shelke, Ajinath Kale, Neha Dagar, et al.
Food & Function (2023) Vol. 14, Iss. 11, pp. 5391-5403
Closed Access | Times Cited: 12
Showing 12 citing articles:
Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Free Radical Research (2024) Vol. 58, Iss. 2, pp. 69-87
Closed Access | Times Cited: 10
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Free Radical Research (2024) Vol. 58, Iss. 2, pp. 69-87
Closed Access | Times Cited: 10
Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress
Tahib Habshi, Hrushikesh Kulkarni, Neha Dagar, et al.
Cell Biology International (2025)
Closed Access | Times Cited: 1
Tahib Habshi, Hrushikesh Kulkarni, Neha Dagar, et al.
Cell Biology International (2025)
Closed Access | Times Cited: 1
High-mobility group box 1 and its related receptors: potential therapeutic targets for contrast-induced acute kidney injury
Changhua Mo, Qili Huang, Lixia Li, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 7, pp. 2291-2299
Closed Access | Times Cited: 4
Changhua Mo, Qili Huang, Lixia Li, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 7, pp. 2291-2299
Closed Access | Times Cited: 4
Empagliflozin in diabetic cardiomyopathy: elucidating mechanisms, therapeutic potentials, and future directions
Aiswarya Jaiswal, Poonam Yadav, Pushkar Singh Rawat, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Aiswarya Jaiswal, Poonam Yadav, Pushkar Singh Rawat, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Combination of α-Klotho and telmisartan attenuates diabetic kidney disease via mitigating EMT, inflammation and apoptosis
Anil Bhanudas Gaikwad, Aditya Dipakrao Hajare, Hrushikesh Kulkarni, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151711-151711
Closed Access
Anil Bhanudas Gaikwad, Aditya Dipakrao Hajare, Hrushikesh Kulkarni, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151711-151711
Closed Access
Esculetin and Phloretin Combination Mitigates Acute Kidney Injury‐Diabetes Comorbidity via Regulating Mitophagy and Inflammation: A Dual‐Pronged Approach
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Phytotherapy Research (2025)
Closed Access
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Phytotherapy Research (2025)
Closed Access
Network pharmacology combined with molecular docking and dynamics to assess the synergism of esculetin and phloretin against acute kidney injury-diabetes comorbidity
Neha Dagar, Hemant R. Jadhav, Anil Bhanudas Gaikwad
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 1-19
Closed Access | Times Cited: 3
Neha Dagar, Hemant R. Jadhav, Anil Bhanudas Gaikwad
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 1-19
Closed Access | Times Cited: 3
Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: A potential therapeutic approach targeting TLR4-induced inflammation
Vishwadeep Shelke, Neha Dagar, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 332, pp. 122095-122095
Closed Access | Times Cited: 8
Vishwadeep Shelke, Neha Dagar, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 332, pp. 122095-122095
Closed Access | Times Cited: 8
Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
Letizia Mattii, Stefania Moscato, Chiara Ippolito, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117278-117278
Open Access | Times Cited: 2
Letizia Mattii, Stefania Moscato, Chiara Ippolito, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117278-117278
Open Access | Times Cited: 2
Phloretamide Protects against Diabetic Kidney Damage and Dysfunction in Diabetic Rats by Attenuating Hyperglycemia and Hyperlipidemia, Suppressing NF-κβ, and Upregulating Nrf2
Rasha Al-Hussan, Nawal A. Albadr, Ghedeir M. Alshammari, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 505-505
Open Access | Times Cited: 2
Rasha Al-Hussan, Nawal A. Albadr, Ghedeir M. Alshammari, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 505-505
Open Access | Times Cited: 2
Management of inflammaging in kidney diseases: focusing on the current investigational drugs
Vishwadeep Shelke, Neha Dagar, Maciej Lech, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1153-1166
Closed Access
Vishwadeep Shelke, Neha Dagar, Maciej Lech, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1153-1166
Closed Access
Recent progress on small molecule TLR4 antagonist against triple-negative breast cancer progression and complications
Darsshen Ramana A L Kathirasan, Siti Nor 'Izzah Binti Normizan, Naguib Salleh, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 118000-118000
Closed Access
Darsshen Ramana A L Kathirasan, Siti Nor 'Izzah Binti Normizan, Naguib Salleh, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 118000-118000
Closed Access
